GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

Clinical trial NCT04601584 · UNKNOWN

Trial details

NCT number: NCT04601584
Sponsor: AO GENERIUM
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-precursor Acute Lymphoblastic Leukemia ALL GNR-084

Start date: 2020-10-15
Primary completion: 2025-02-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.